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INTRODUCTION 
Madhumeha finds a strong co-relation and similarity 
with Diabetes Mellitus. Madhumeha vis-à-vis Diabetes 
mellitus is a group of metabolic disorder characterized  
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by Hyperglycaemia resulting from defects in Insulin 
secretion or its Action.
[1]
 Charaka, Sushruta, Vagbhata 
and other Acharyas mentioned Apatarpana Chikitsa 
for Sthoola and Balavan Pramehi.
[2],[3] 
In classics the prime importance has been given to 
Basti among Panchakarma and even termed as 
Ardhachikitsa or complete Chikitsa, as it produces 
multi-dimensional effect. It is mainly indicated in 
Vataja, Pittaja, Kaphaja, Raktaja, Dwidoshaja, Tri-
doshaja and also in Aavaranajanya Rogas.
[4]
 Basti is 
prepared with specific combination of drugs or a 
drugs to a particular disease, it acts soon and does 
easy evacuation of Malas, produces Apatarpana, 
Tarpana, Rokshana, Balya, Vrishya, Rasayana etc. 
With these qualities it is said that it is superior to 
other Shodhana therapies.
[5],[6]
 Charaka’s concept of 
Aavapa Dravya and its importance in the preparation 
A B S T R A C T  
Background: Madhumeha has become a burning issue in day today life. The term Prameha has 
broader connotations indicating the increased quantity and quality of urination. Where as Madhumeha, 
is the condition where patient passes urine like honey. Madhumeha vis-à-vis Diabetes mellitus is a 
group of metabolic disorder characterized by Hyperglycaemia resulting from defects in Insulin 
secretion or its Action. In classics the prime importance has been given to Basti among Panchakarma 
and even termed as Ardhachikitsa or complete Chikitsa, as it produces multi-dimensional effect.  
Objectives: To evaluate the efficacy of the Vasti in Trio-vasti pattern and also to evaluate the efficacy 
of the Avapadravya in Vasti in Madhumeha, Methodology: 30 patients were selected for the study and 
equally divided in three groups. Group-A: 10 patients received Somavalka Kashaya Niruha Yoga Basti. 
Group-B: 10 patients received Somavalka Kashaya with Aavapa Dravya Niruha Yoga Basti. Group-C: 
10 patients received Somavalka Kashaya Niruha Yoga Basti in Trio-vasti pattern. Results and 
Conclusion: After proper administration of Somavalka Kashaya Yogabasti in all the groups the results 
were noted that, it gives immediate and lasting results, both symptomatically and in sugar levels. 
Among 30 patients, 7 patients (23.33%) showed mild response, 12 Patients (40%) showed moderate 
response, 11 patients (36.66%) showed marked response. In mild and moderate type of Madhumeha 
patients, Somavalka Kashaya given in Trio-Basti helps to control it. Along with Bastikarma, 
administration of Patya Aahara- Vihara and Shamanoushadis may give better effect. 
Key words: Samshodhana, Madhumeha, Diabetes mellitus, Aavapa dravya Basti, Trio-vasti. 
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of Vasti is remarkable.
[7]
 Sushruta has dealt the 
concept of Trio-Vasti i.e. Dosha Utkleshana, 
Doshahara and Doshashamana and suggests following 
this pattern to achieve proper effect of Vasti in 
eliminating Dosha and to subside a disease by one’s 
own intellect.
[8]
  
Charaka has indicated Somavalka (Vit khadira) Niruha 
in Prameha (Madhumeha).
[9]
 Numbers of research 
works have already been conducted on Madhumeha. 
It is one of the multi systemic disorders where the 
maximum numbers of Srotas involved. So treating 
such disease with some time tested and effective 
therapies like Vasti is the better option. 
OBJECTIVES 
1. To evaluate the efficacy of the Vasti in Trio-vasti 
pattern. 
2. To evaluate the efficacy of the Avapadravya in 
Vasti in Madhumeha 
MATERIALS AND METHODS 
Study design: It’s a Comparative clinical trial.  
Source of Data: Patients suffering from Madhumeha 
were selected from Panchakarma O.P.D. of S.J.G. 
Ayurvedic Medical College and Hospital, Koppal by 
preset inclusion and exclusion criteria. 
Sample Size and Grouping: A Minimum of 30 patients 
were selected for the study and equally divided in 
three groups. 
Group-A: 10 patients were received Somavalka 
Kashaya Niruha Yoga Basti. 
Group-B: 10 patients were received Somavalka 
Kashaya with Aavapa dravya Niruha Yoga Basti. 
Group-C: 10 patients were received Somavalka 
Kashaya Niruha Yoga Basti in Trio-vasti pattern. 
Diagnostic Criteria: The diagnosis of the disease 
Madhumeha was made according to signs and 
symptoms mentioned in Ayurvedic and Modern texts. 
Exclusion Criteria 
1. Age below 30 Years and Above 60 Years 
2. Insulin Dependent 
3. Hypertensive 
4. Ischemic heart disease Patients 
5. Diabetic Ketoacidosis 
6. Other Systemic Disorders 
7. Non-diabetic Glycosuria. 
8. Gestational Diabetes Mellitus 
9. Patients with Severe Diabetic complications. 
Inclusive Criteria 
1. Madhumeha patients of classical signs and 
symptoms 
2. Irrespective of Gender bias 
3. Fasting blood sugar more than 110 mg/dl to 250 
mg/dl 
4. Post prandial blood sugar more than 140 mg/dl to 
300mg/dl  
Plan of study 
Shodhana (Basti) therapy was divided into 
Poorvakarma, Pradhanakarma and Paschatkarma. 
Poorvakarma: For all the 3 Groups 
 Deepana / Pachana for 3 days 
 Mridu Anulomana for 1 day. 
 Shtanika Snehana and Shtanika Swedana done as 
a Tatkaleena Purvakarma for all the patients. 
 Laghu Bhojana was advised before administration 
of Anuvasana. 
 Niruha Basti was administered in empty stomach 
Pradhana Karma 
Group-A: Patients received Somavalka Kashaya Yoga 
Basti after assessing the status of patient’s Koshta, 
Bala, etc. which includes 5 Somavalka Taila 
Anuvasana and 3 Somavalka Kashaya Niruha. 
Group-B: Patients received Somavalka plus Aavapa 
Dravya Kashaya Yoga Basti after assessing the status 
of patient’s Koshta, Bala, etc. which includes 5 
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Somavalka Taila Anuvasana and 3 Somavalka plus 
Aavapa Dravya Kashaya Niruha. 
Group-C: Patients received Somavalkakashaya Yoga 
Basti in Trio-vasti pattern after assessing the status of 
patient’s Koshta, Bala, etc. which includes 5 
Somavalka Taila Anuvasana and 3 Niruha which 
includles first Niruha with Somavalka plus Yastimadhu 
and Kapitta Kashaya. Second Niruha with Somavalka 
plus Karavellaka and Nimba Kashaya, third Niruha 
with Somavalka plus Saptachakra and Jambu 
Kashaya. 
Group A 
Days  1
st
 
day 
2
nd
 
day 
3
rd
 
day 
4
th
 
day 
5
th
 
day 
6
th
 
day 
7
th
 
day 
8
th
 
day 
Basti 
Dravya 
A N A N A N A A 
 A = Anuvasana with Somavalakala Taila - 75ml 
 N = Niruha with Somavalakala Kashaya 
Niruha Vasti Dravyas & Basti Dosage 
Makshika  120ml 
Lavana  12gms 
Sneha  100ml 
Kalka  15gms 
Somavalka Kashaya  500ml 
Total quantity 720ml 
Group B 
Days  1
st
 
day 
2
nd
 
day 
3
rd
 
day 
4
th
 
day 
5
th
 
day 
6
th
 
day 
7
th
 
day 
8
th
 
day 
Basti 
Dravya 
A N A N A N A A 
 A = Anuvasana with Somavalakala Taila 75ml 
 N = Niruha with Somavalakala Kashaya + Avapa 
Dravyas (Amalaki 10gms & Haridra 10gms) 
Makshika  120ml 
Lavana  12gms 
Sneha  100ml 
Kalka  15gms 
Kashaya  500ml 
Avapa Dravyas 20gms 
Total quantity 720ml 
Group C 
Days  1
st
 
day 
2
nd
 
day 
3
rd
 
day 
4
th
 
day 
5
th
 
day 
6
th
 
day 
7
th
 
day 
8
th
 
day 
Basti 
Dravya 
A N A N A N A A 
 A = Anuvasana with Somavalakala Taila 75ml 
 Dosage of 3 Niruha Bastis administered in 
following manner. 
1
st
 Niruha 2
nd
 Niruha 3
rd
 Niruha 
Makshika  120m
l 
Makshika  120m
l 
Makshika  120m
l 
Lavana  12gm
s 
Lavana  12gm
s 
Lavana  12gm
s 
Sneha  100m
l 
Sneha  100m
l 
Sneha  100m
l 
Kalka  15gm
s 
Kalka  15gm
s 
Kalka  15gm
s 
Kashaya  300m
l 
Kashaya  300m
l 
Kashaya  300m
l 
Yashtimadh
u Kashaya 
150m
l 
Nimbi 
Kashaya 
150m
l 
Jambu 
Kashaya 
150m
l 
Kapittha 
Kashaya 
150m
l 
Karavellak
a Kashaya 
150m
l 
Saptachakr
a Kashaya 
150m
l 
Total 
quantity 
820m
l 
Total 
quantity 
820m
l 
Total 
quantity 
820m
l 
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Paschat Karma: Patya Ahara- Vihara  
Follow-up : 16 days (Parihara Kala).  
Study Duration: 12 days Treatment + 16 days follow 
up = Total 28 days 
Investigations: FBS, PPBS, FUS, PPUS. 
Subjective Parameters 
1. Prabhoota Mootrata  
2. Avila Mootrata   
3. Alasya    
4. Pipasadhikya  
5. Kara-Pada Daha and Suptata 
6. Ati Sweda 
7. Gurugatrata 
8. Dourbalya 
Objective Parameters 
Blood : FBS, PPBS. 
Urine : Urine sugar (Fasting and Post Prandial). 
SN Level FBS PPBS Urine 
sugar 
1. Normal 70-120 mg/dl. 120-180 mg/dl Nil 
2. Mild 121-170 mg/dl 181-230 mg/dl 0.5% 
3. Moderate 171-220 mg/dl 231-280 mg/dl 1.0-1.5 % 
4. Severe 221- mg/dl 
and above 
281 mg/dl and 
above 
2% and 
above 
Method of assessment of grading 
The assessment of results was assessed by observing 
the severity of symptoms, as well as the laboratory 
investigations. 
Gradings of subjective parameters 
1. Prabhuta Mootrata 
Frequency 
Grade 0 - 2-3 times/day; 1 times/night 
Grade 1 - 4-6 times/day; 2 times/night 
Grade 2 - 7-9 times/day; 3-4times/night 
Grade 3 - 10 times/day; >5times/night 
2. Avila Mootrata 
Grade 0 - Clear 
Grade 1 - Milky white 
Grade 2 - Buffy 
Grade 3 - More turbidity 
3. Kara Pada Daha 
Grade 0 - No kara padadadha 
Grade 1-  Occasionally noticed 
Grade 2 - Periodically noticed 
Grade 3 - Daily noticed 
4. Aalasya 
Grade 0 - No Aalasya 
Grade 1 - Mild increased but tolerated 
Grade 2 - Moderate increased but tolerated 
Grade 3 - Severally increased but not tolerated 
5. Pipasa 
Grade 0 : Normal 
Grade 1 : Mild increased but tolerated 
Grade 2 : Moderate increased but tolerated 
Grade 3 : Severally increased but not Tolerated 
6. Atisweda 
Grade 0 : Normal sweating after doing normal physical 
activities 
Grade 1 : Moderate sweating 
Grade 2 : Excessive sweating 
Grade 3 : Excessive sweating just by doing little work 
7. Dourbalya 
Grade 0 : No Dourbalya 
Grade 1 : Occasionally noticed but not periodically 
Grade 2 : Periodically noticed 
Grade 3 : Continuously noticed 
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8. Gurugatrata 
Grade 0 : No Gurugatrata 
Grade 1 : Occasionally noticed but not periodically 
Grade 2 : Periodically noticed 
Grade 3 : Continuously noticed 
Gradings for objective parameters 
Blood Sugar 
Grades  Fasting  Post-prandial 
Grade 0 <110 mg% <140 mg% 
Grade 1 111 – 145 mg% 141 – 180 mg% 
Grade 2 146 – 180 mg% 181 – 220 mg% 
Grade 3 181- 215 mg% 221 – 260 mg% 
Grade 4 216 – 250 mg% 261 – 300 mg% 
Urine Sugar 
Grade 0 Nil 
Grade 1 0.5% 
Grade 2 01% 
Grade 3 1.5% 
Grade 4 02% 
OBSERVATIONS 
Among 30 patients 17 (56.6%) were Males and 13 
patients (43.3%) were Female. Among 30 Patients 28 
(93.3%) were Hindus and 2 (6.6%) Patients were 
Muslims.  Among 30 Patients 10 (33.33%) had Present 
20 (66.66%) Patients had Absent Family History. 
Among 30 patients 18 (60%) were Vegitarian and 12 
patients (40%) were Female. Among 30 patients 6 
(20%) had sound sleep and 24 patients (80%) had 
Disturbed sleep. Among 30 Patients 6 (20%) were 
having Vatapitta, 16 (53.3%) were having Vatakapha, 
4 (13.3%) were having Pittakapha and 4 (13.3%) were 
having Sama Prakruti. Among 30 Patients 10 (33.3%) 
Patients had 1-2 years, 12 (40%)  Patients had 2-5 
years, 8 Among 30 Patients 5 (16.6%) were Samagni, 
3(3%) were Vishamagni, 12(40%) were Teekshagni, 10 
were having Mandagni. Among 30 Patients 4 (13.3%) 
were Mridu, 20 (66.6%) were Madyama, 6 (20%) were 
Krura Koshta. Among 30 Patients 3 (10%) were 
Pravara, 20 (66.6%) were Madhyama, 7 (23.3%) were 
Avara Sara. Among 30 Patients 4 (13.3%) were 
Pravara, 16 (53.3%) were Madhyama, 10 (33.3%) 
were Avara Samhanana. Among 30 Patients 20 
(66.6%) were Pravara, 10 (33.3%) were Madhyama 
Satmya. Among 30 Patients 12 (40%) were Pravara, 7 
(23.3%) were Madhyama, 11 (36.6%) were Avara 
Satwa. Among 30 Patients 18 (60%) were Pravara, 10 
(33.3%) were Madhyama, 2 (6.6%) Patients were 
having Avara Abhyavaranashakti. Among 30 Patients 
18(60%) were Pravara, 8(26.6%) were Madhyama, 4 
(13.3%) Patients were having Avara Jaranashakti. 
Among 30 Patients 3 (10%) were Pravara, 19 (63.3%) 
were Madhyama, 8 (26.6%) Patients were having 
Avara Vyayamashakti. Among 30 Patients 3 (10%) 
were having Upadrava and 27 (90%) were not having 
Upadrava. 
In symptom Prabhuta Mutrata, all the patients of all 3 
Groups showed Highly Significant response (as 
P<0.001) after the Treatment and Significant after the 
Follow-up period as the P value is <0.01. 
In symptom Avila Mutrata, all the patients of all 3 
Groups showed Insignificant response as P>0.05 after 
the Treatment and even after the Follow-up period 
also, as the P value is >0.05. 
In symptom Kara Pada Daha and Suptata, all the 
patients of all 3 Groups showed Significant response 
(P<0.01) after the Treatment and Moderate 
significance after the Follow-up period, as the P value 
is <0.05. 
In symptom Alasya, all the patients of all 3 Groups 
showed Insignificant response (P>0.05) after the 
Treatment and Moderate response after the Follow-
up period, as the P value is <0.05. 
In symptom Pipasadhikya, all the patients of all 3 
Groups showed Significant response after the 
Treatment and even after the Follow-up period also, 
as the P value is <0.01 
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In symptom Atisweda, all the patients of all 3 Groups 
showed Insignificant response after the Treatment 
and even after the Follow-up period also, as the P 
value is >0.05. 
In symptom Dourbalya, all the patients of all 3 Groups 
showed Insignificant response after the Treatment 
and even after the Follow-up period also, as the P 
value is >0.05. 
In symptom Gurugatrata, all the patients of all 3 
Groups showed Insignificant response after the 
Treatment and even after the Follow-up period also, 
as the P value is >0.05. 
Table 1: Prabhuta Mutrata in Different Groups 
Comparisons. 
Obser
vation
s  
Descriptives Kruskal-Wallis H Test 
Com
parin
g 
Grou
ps 
n M
ea
n 
±S
D 
±S
E 
M
ea
n 
Ra
nk 
d
f 
Chi
-
Sq
uar
e 
P Re
mar
ks 
After 
Treat
ment 
Grou
p-A 
1
0 
1.
6 
0.
51
6 
0.
16
3 
21
.5
0 
2 15.
08 
<0.
00
1 
HS 
Grou
p-B 
1
0 
1.
2 
0.
78
9 
0.
24
9 
17
.5
0 
Grou
p-C 
1
0 
0.
2 
0.
42
2 
0.
13
3 
7.
50 
Total 3
0 
1.
0 
0.
83
0 
0.
15
2 
 - 
After 
Follo
w-up 
Grou
p-A 
1
0 
1.
9 
0.
56
8 
0.
18
0 
21
.4
5 
2 11.
07 
<0.
01 
S 
Grou
p-B 
1
0 
1.
4 
0.
51
6 
0.
16
3 
15
.4
0 
Grou
p-C 
1
0 
0.
9 
0.
56
8 
0.
18
0 
9.
65 
Total 3
0 
1.
4 
0.
67
5 
0.
12
3 
 - 
 
Table 2: Avila Mutrata in Different Groups 
Comparisons. 
Obser
vation
s  
Descriptives Kruskal-Wallis H Test 
Com
parin
g 
Grou
ps 
n M
ea
n 
±S
D 
±S
E 
M
ea
n 
Ra
nk 
d
f 
Chi
-
Sq
uar
e 
P Re
mar
ks 
After 
Treat
ment 
Grou
p-A 
1
0 
0.
6 
0.
84
3 
0.
26
7 
18
.3
0 
2 3.0
2 
>0
.0
5 
IS 
Grou
p-B 
1
0 
0.
2 
0.
42
2 
0.
13
3 
14
.8
0 
Grou
p-C 
1
0 
0.
1 
0.
31
6 
0.
10
0 
13
.4
0 
Total 3
0 
0.
3 
0.
59
6 
0.
10
9 
 - 
After 
Follow
-up 
Grou
p-A 
1
0 
0.
8 
1.
13
5 
0.
35
9 
17
.6
0 
2 1.6
0 
>0
.0
5 
IS 
Grou
p-B 
1
0 
0.
4 
0.
69
9 
0.
22
1 
15
.3
0 
Grou
p-C 
1
0 
0.
2 
0.
42
2 
0.
13
3 
13
.6
0 
Total 3
0 
0.
5 
0.
81
9 
0.
15
0 
 - 
 
Table 3: Kara Pada Daha / Suptata in Different 
Groups Comparisons. 
Obser
vation
s  
Descriptives Kruskal-Wallis H Test 
Com
parin
g 
Grou
ps 
n M
ea
n 
±S
D 
±S
E 
M
ea
n 
Ra
nk 
d
f 
Chi
-
Sq
uar
e 
P Re
mar
ks 
After 
Treat
ment 
Grou
p-A 
1
0 
1.
0 
0.
47
1 
0.
14
9 
20
.0
0 
2 10.
12 
<0
.0
1 
S 
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 Grou
p-B 
1
0 
0.
8 
0.6
32 
0.2
00 
17.
20 
    
Grou
p-C 
1
0 
0.
2 
0.4
22 
0.1
33 
9.3
0 
Tota
l 
3
0 
0.
7 
0.6
06 
0.1
11 
 - 
After 
Follo
w-up 
Grou
p-A 
1
0 
1.
4 
0.6
99 
0.2
21 
20.
85 
2 8.5
7 
<0.
05 
M
S 
Grou
p-B 
1
0 
0.
9 
0.7
38 
0.2
33 
15.
55 
Grou
p-C 
1
0 
0.
4 
0.5
16 
0.1
63 
10.
10 
Tota
l 
3
0 
0.
9 
0.7
59 
0.1
39 
 - 
 
Table 4: Aalasya in Different Groups Comparisons. 
Obser
vation
s 
Descriptives Kruskal-Wallis H Test 
Com
parin
g 
Grou
ps 
n M
ea
n 
±S
D 
±S
E 
M
ea
n 
Ra
nk 
d
f 
Chi
-
Sq
uar
e 
P Re
mar
ks 
After 
Treat
ment 
Grou
p-A 
1
0 
0.
2 
0.
42
2 
0.
13
3 
17
.5
0 
2 4.1
4 
>0
.0
5 
IS 
Grou
p-B 
1
0 
0.
0 
0.
00
0 
0.
00
0 
14
.5
0 
Grou
p-C 
1
0 
0.
0 
0.
00
0 
0.
00
0 
14
.5
0 
Total 3
0 
0.
1 
0.
25
4 
0.
04
6 
 - 
After 
Follow
-up 
Grou
p-A 
1
0 
0.
7 
0.
82
3 
0.
26
0 
19
.3
0 
2 6.5
8 
<0
.0
5 
MS 
Grou
p-B 
1
0 
0.
0 
0.
00
0 
0.
00
0 
11
.5
0 
 
 Group-
C 
10 0.3 0.483 0.153 15.70     
Total 30 0.3 0.606 0.111  - 
 
Table 5: Pipasadhikya in Different Groups 
Comparisons. 
Obser
vation
s  
Descriptives Kruskal-Wallis H Test 
Com
parin
g 
Grou
ps 
n M
ea
n 
±S
D 
±S
E 
M
ea
n 
Ra
nk 
d
f 
Chi
-
Sq
uar
e 
P Re
mar
ks 
After 
Treat
ment 
Grou
p-A 
1
0 
1.
2 
0.
42
2 
0.
13
3 
21
.5
0 
2 12.
03 
<0
.0
1 
S 
Grou
p-B 
1
0 
0.
7 
0.
48
3 
0.
15
3 
15
.3
0 
Grou
p-C 
1
0 
0.
3 
0.
48
3 
0.
15
3 
9.
70 
Total 3
0 
0.
7 
0.
58
3 
0.
10
6 
 - 
After 
Follow
-up 
Grou
p-A 
1
0 
1.
8 
0.
63
2 
0.
20
0 
22
.3
5 
2 11.
93 
<0
.0
1 
S 
Grou
p-B 
1
0 
1.
0 
0.
66
7 
0.
21
1 
13
.8
0 
Grou
p-C 
1
0 
0.
7 
0.
48
3 
0.
15
3 
10
.3
5 
Total 3
0 
1.
2 
0.
74
7 
0.
13
6 
 - 
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Table 6: Atisweda in Different Groups Comparisons. 
Obser
vation
s 
Descriptives Kruskal-Wallis H Test 
Com
parin
g 
Grou
ps 
n M
ea
n 
±S
D 
±S
E 
M
ea
n 
Ra
nk 
d
f 
Chi
-
Sq
uar
e 
P Re
mar
ks 
After 
Treat
ment 
Grou
p-A 
1
0 
0.
9 
0.
87
6 
0.
27
7 
17
.7
0 
2 1.3
8 
>0
.0
5 
IS 
Grou
p-B 
1
0 
0.
5 
0.
70
7 
0.
22
4 
13
.5
0 
Grou
p-C 
1
0 
0.
6 
0.
51
6 
0.
16
3 
15
.3
0 
Total 3
0 
0.
7 
0.
71
1 
0.
13
0 
 - 
After 
Follow
-up 
Grou
p-A 
1
0 
1.
3 
1.
05
9 
0.
33
5 
19
.4
0 
2 3.4
0 
>0
.0
5 
IS 
Grou
p-B 
1
0 
0.
6 
0.
84
3 
0.
26
7 
13
.2
0 
Grou
p-C 
1
0 
0.
6 
0.
51
6 
0.
16
3 
13
.9
0 
Total 3
0 
0.
8 
0.
87
4 
0.
16
0 
 - 
 
Table 7: Daurbalya in Different Groups Comparisons. 
Obser
vation
s 
Descriptives Kruskal-Wallis H Test 
Com
parin
g 
Grou
ps 
n M
ea
n 
±S
D 
±S
E 
M
ea
n 
Ra
nk 
d
f 
Chi
-
Sq
uar
e 
P Re
mar
ks 
After 
Treat
ment 
Grou
p-A 
1
0 
0.
7 
0.
82
3 
0.
26
0 
18
.2
5 
2 2.1
9 
>0
.0
5 
IS 
Grou 1 0. 0. 0. 13
p-B 0 3 67
5 
21
3 
.7
0 
Grou
p-C 
1
0 
0.
3 
0.
48
3 
0.
15
3 
14
.5
5 
Total 3
0 
0.
4 
0.
67
9 
0.
12
4 
 - 
After 
Follow
-up 
Grou
p-A 
1
0 
0.
9 
0.
87
6 
0.
27
7 
19
.4
5 
2 4.4
3 
>0
.0
5 
IS 
Grou
p-B 
1
0 
0.
4 
0.
69
9 
0.
22
1 
14
.4
5 
Grou
p-C 
1
0 
0.
2 
0.
42
2 
0.
13
3 
12
.6
0 
Total 3
0 
0.
5 
0.
73
1 
0.
13
3 
 - 
 
Table 8: Gurugatrata in Different Groups 
Comparisons. 
Obser
vation
s 
Descriptives Kruskal-Wallis H Test 
Com
parin
g 
Grou
ps 
n M
ea
n 
±S
D 
±S
E 
M
ea
n 
Ra
nk 
d
f 
Chi
-
Sq
uar
e 
P Re
mar
ks 
After 
Treat
ment 
Grou
p-A 
1
0 
0.
4 
0.
69
9 
0.
22
1 
16
.7
0 
2 0.5
1 
>0
.0
5 
IS 
Grou
p-B 
1
0 
0.
2 
0.
42
2 
0.
13
3 
14
.9
0 
Grou
p-C 
1
0 
0.
2 
0.
42
2 
0.
13
3 
14
.9
0 
Total 3
0 
0.
3 
0.
52
1 
0.
09
5 
 - 
After 
Follow
-up 
Grou
p-A 
1
0 
0.
5 
0.
70
7 
0.
22
4 
18
.1
5 
2 2.7
6 
>0
.0
5 
IS 
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Grou
p-B 
1
0 
0.
1 
0.
31
6 
0.
10
0 
13
.4
5 
Grou
p-C 
1
0 
0.
2 
0.
42
2 
0.
13
3 
14
.9
0 
Total 3
0 
0.
3 
0.
52
1 
0.
09
5 
 - 
 
Table 9: Effect of therapy on FBS  
Gro
ups 
Samples 
Statistics 
Paired Differences Paired t-Test 
findings 
Gro
up-
A 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±
S
E 
t P Rem
arks 
B
T 
20
3.
3 
A
T 
16
2.
0 
20% BT-AT 1
0 
14
.1
0 
4.
4
6 
9.
2
7 
<0.
00
1 
HS 
A
F 
17
4.
7 
14% BT-AF 1
0 
22
.5
7 
7.
1
4 
4.
0
1 
<0.
01 
S 
Gro
up-
B 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±
S
E 
t P Rem
arks 
B
T 
18
0.
2 
A
T 
13
5.
5 
25% BT-AT 1
0 
25
.4
2 
8.
0
4 
5.
5
6 
<0.
00
1 
HS 
A
F 
14
8.
5 
18% BT-AF 1
0 
20
.0
3 
6.
3
3 
5.
0
1 
<0.
00
1 
HS 
Gro
up-
C 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±
S
E 
t P Rem
arks 
B
T 
18
0.
1 
A
T 
11
1.
7 
38% BT-AT 1
0 
21
.7
0 
6.
8
6 
9.
9
7 
<0.
00
1 
HS 
A
F 
13
5.
7 
25% BT-AF 1
0 
18
.7
1 
5.
9
2 
7.
5
0 
<0.
00
1 
HS 
In symptom FBS, all the patients of all 3 Groups 
showed Highly significant response after the 
Treatment and even after the Follow-up period as the 
P value is <0.001, except in Group A – patients 
showed Significance results after the follow-up period 
as P is <0.01. 
Table 10: FBS in Different Groups Comparisons 
Obs
erva
tion
s 
Descriptives ANOVA 
Co
mp
ari
ng 
Gro
ups 
n M
e
a
n 
±
S
D 
±
S
E 
Va
ria
nc
e 
Su
m 
of 
Sq
ua
re
s 
d
f 
M
ea
n 
Sq
ua
re 
F P Re
m
ar
ks 
Afte
r 
Trea
tme
nt 
Gro
up-
A 
1
0 
1
6
2.
0 
2
0
.
1 
6
.
4 
Be
tw
ee
n 
Gr
ou
ps 
12
66
2.
6 
2 63
31
.3 
1
7.
6
0 
<
0.
0
1 
S 
Gro
up-
B 
1
0 
1
3
5.
5 
2
2
.
1 
7
.
0 
Gro
up-
C 
1
0 
1
1
1.
7 
1
3
.
7 
4
.
3 
Wi
thi
n 
Gr
ou
ps 
97
12
.6 
2
7 
35
9.
7 
Tot
al 
3
0 
1
3
6.
4 
2
7
.
8 
5
.
1 
Afte
r 
Foll
ow-
up 
Gro
up-
A 
1
0 
1
7
4.
7 
2
6
.
5 
8
.
4 
Be
tw
ee
n 
Gr
ou
ps 
79
04
.3 
2 39
52
.1 
9.
1
0 
<
0.
0
1 
S 
Gro
up-
B 
1
0 
1
4
8.
5 
1
9
.
5 
6
.
2 
Gro
up-
C 
1
0 
1
3
5.
7 
1
4
.
9 
4
.
7 
Wi
thi
n 
Gr
ou
ps 
11
72
4.
7 
2
7 
43
4.
2 
Tot
al 
3
0 
1
5
3.
2
6
.
4
.
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0 0 8 
In symptom PPBS, Group-B and Group-C showed 
Highly significant response after the treatment and 
after the fallow-up period also as P<0.001, whereas in  
Group-A  patients were had Highly significance after 
the treatment as P<0.001 and Significant after the 
fallow-up period as P<0.01. 
Table 11: PPBS in Different Groups Comparisons 
Obs
erva
tion
s 
Descriptives ANOVA 
Co
mp
ari
ng 
Gro
ups 
n M
e
a
n 
±
S
D 
±
S
E 
Va
ria
nc
e 
Su
m 
of 
Sq
ua
re
s 
d
f 
M
ea
n 
Sq
ua
re 
F P Re
m
ar
ks 
Afte
r 
Trea
tme
nt 
Gro
up-
A 
1
0 
1
8
7.
8 
3
0
.
6 
9
.
7 
Be
tw
ee
n 
Gr
ou
ps 
12
22
3.
4 
2 61
11
.7 
1
1.
8
8 
<
0.
0
1 
S 
Gro
up-
B 
1
0 
1
6
4.
9 
1
9
.
7 
6
.
2 
Gro
up-
C 
1
0 
1
3
8.
4 
1
4
.
9 
4
.
7 
Wi
thi
n 
Gr
ou
ps 
13
88
6.
9 
2
7 
51
4.
3 
Tot
al 
3
0 
1
6
3.
7 
3
0
.
0 
5
.
5 
Afte
r 
Foll
ow-
up 
Gro
up-
A 
1
0 
2
0
9.
7 
2
1
.
8 
6
.
9 
Be
tw
ee
n 
Gr
ou
ps 
16
41
6.
2 
2 82
08
.1 
2
0.
0
1 
<
0.
0
1 
S 
Gro
up-
B 
1
0 
1
7
5.
4 
2
3
.
0 
7
.
3 
Gro
up-
C 
1
0 
1
5
2.
8 
1
5
.
0 
4
.
8 
Wi
thi
n 
Gr
ou
11
07
4.
1 
2
7 
41
0.
2 
Tot 3 1 3 5
al 0 7
9.
3 
0
.
8 
.
6 
ps 
In symptom PPBS, all the patients of all 3 Groups 
showed Significant response after the Treatment and 
even after the Follow-up period also as the P value is 
<0.01. 
Table 12: Effect of therapy on FUS  
Gro
ups 
Samples 
Statistics 
Paired Differences Paired t-Test 
findings 
G
ro
u
p
-A
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
1.
2
5 
A
T 
0.
6
5 
48% BT-AT 1
0 
0.
39
4 
0.
12
5 
4.
8
1 
<0.
00
1 
HS 
A
F 
0.
9
0 
28% BT-AF 1
0 
0.
33
8 
0.
10
7 
3.
2
8 
<0.
01 
S 
G
ro
u
p
-B
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
0.
9
5 
A
T 
0.
2
5 
74% BT-AT 1
0 
0.
35
0 
0.
11
1 
6.
3
3 
<0.
00
1 
HS 
A
F 
0.
5
0 
47% BT-AF 1
0 
0.
43
8 
0.
13
8 
3.
2
5 
<0.
01 
S 
G
ro
u
p
-C
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
0.
7
5 
A
T 
0.
2
0 
73% BT-AT 1
0 
0.
28
4 
0.
09
0 
6.
1
3 
<0.
00
1 
HS 
A
F 
0.
2
0 
73% BT-AF 1
0 
0.
28
4 
0.
09
0 
6.
1
3 
<0.
00
1 
HS 
In symptom FUS, all the patients of all 3 Groups 
showed Highly significant response after the 
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Treatment and even after the Follow-up period as the 
P value is <0.001, except in Group A and Group B– 
patients showed Significance results after the fallow-
up period as P is <0.01. 
Table 13: FUS in Different Groups Comparisons 
Obs
erva
tion
s 
Descriptives ANOVA 
Co
mp
ari
ng 
Gro
ups 
n M
e
a
n 
±
S
D 
±
S
E 
Va
ria
nc
e 
Su
m 
of 
Sq
ua
re
s 
d
f 
M
ea
n 
S
q
u
ar
e 
F P Re
m
ar
ks 
Afte
r 
Trea
tme
nt 
Gro
up-
A 
1
0 
0.
6
5 
0.
3
3
8 
0.
1
0
7 
Be
tw
ee
n 
Gr
ou
ps 
1.
21
7 
2 0.
6
0
8 
5.
9
7 
<
0.
0
1 
S 
Gro
up-
B 
1
0 
0.
2
5 
0.
3
5
4 
0.
1
1
2 
Gro
up-
C 
1
0 
0.
2
0 
0.
2
5
8 
0.
0
8
2 
Wi
thi
n 
Gr
ou
ps 
2.
75
0 
2
7 
0.
1
0
2 
Tot
al 
3
0 
0.
3
7 
0.
3
7
0 
0.
0
6
8 
Afte
r 
Foll
ow-
up 
Gro
up-
A 
1
0 
0.
9
0 
0.
2
1
1 
0.
0
6
7 
Be
tw
ee
n 
Gr
ou
ps 
2.
46
7 
2 1.
2
3
3 
1
6.
6
5 
<
0.
0
1 
S 
Gro
up-
B 
1
0 
0.
5
0 
0.
3
3
3 
0.
1
0
5 
Gro
up-
C 
1
0 
0.
2
0 
0.
2
5
8 
0.
0
8
2 
Wi
thi
n 
Gr
ou
ps 
2.
00
0 
2
7 
0.
0
7
4 
Tot
al 
3
0 
0.
5
3 
0.
3
9
3 
0.
0
7
2 
 
Table 14: Effect of therapy on PPUS 
Gro
ups 
Samples 
Statistics 
Paired Differences Paired t-Test 
findings 
G
ro
u
p
-A
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
1.
3
5 
A
T 
1.
0
0 
26% BT-AT 1
0 
0.
24
2 
0.
07
6 
4.
5
8 
<0.
01 
S 
A
F 
1.
0
5 
22% BT-AF 1
0 
0.
25
8 
0.
08
2 
3.
6
7 
<0.
01 
S 
G
ro
u
p
-B
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
0.
9
0 
A
T 
0.
2
0 
78% BT-AT 1
0 
0.
42
2 
0.
13
3 
5.
2
5 
<0.
00
1 
HS 
A
F 
0.
3
5 
61% BT-AF 1
0 
0.
36
9 
0.
11
7 
4.
7
1 
<0.
01 
S 
G
ro
u
p
-C
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
0.
9
0 
A
T 
0.
1
5 
83% BT-AT 1
0 
0.
35
4 
0.
11
2 
6.
7
1 
<0.
00
1 
HS 
A
F 
0.
1
5 
83% BT-AF 1
0 
0.
35
4 
0.
11
2 
6.
7
1 
<0.
00
1 
HS 
In symptom PPUS, all the patients of Group-C showed 
Highly significant response after the Treatment and 
even after the Follow-up period as the P value is 
<0.001. Group-B showed Highly significant response 
after the Treatment as the P value is <0.001 and 
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Significant response after the Follow-up period as the 
P value is <0.01. in Group A – patients showed 
Significance results after the treatment and even after 
the fallow-up period also as P is <0.01. 
Table 15: PPUS in Different Groups Comparisons 
Obs
erva
tion
s 
Descriptives ANOVA 
Co
mp
ari
ng 
Gro
ups 
n M
e
a
n 
±
S
D 
±
S
E 
Va
ria
nc
e 
Su
m 
of 
Sq
ua
re
s 
d
f 
M
ea
n 
S
q
u
ar
e 
F P Re
m
ar
ks 
Afte
r 
Trea
tme
nt 
Gro
up-
A 
1
0 
1.
0
0 
0.
4
0
8 
0.
1
2
9 
Be
tw
ee
n 
Gr
ou
ps 
4.
55
0 
2 2.
2
7
5 
2
3.
4
0 
<
0.
0
1 
S 
Gro
up-
B 
1
0 
0.
2
0 
0.
2
5
8 
0.
0
8
2 
Gro
up-
C 
1
0 
0.
1
5 
0.
2
4
2 
0.
0
7
6 
Wi
thi
n 
Gr
ou
ps 
2.
62
5 
2
7 
0.
0
9
7 
Tot
al 
3
0 
0.
4
5 
0.
4
9
7 
0.
0
9
1 
Afte
r 
Foll
ow-
up 
Gro
up-
A 
1
0 
1.
0
5 
0.
3
6
9 
0.
1
1
7 
Be
tw
ee
n 
Gr
ou
ps 
4.
46
7 
2 2.
2
3
3 
2
1.
7
3 
<
0.
0
1 
S 
Gro
up-
B 
1
0 
0.
3
5 
0.
3
3
8 
0.
1
0
7 
Gro
up-
C 
1
0 
0.
1
5 
0.
2
4
2 
0.
0
7
6 
Wi
thi
n 
Gr
ou
ps 
2.
77
5 
2
7 
0.
1
0
3 
Tot
al 
3
0 
0.
5
2 
0.
5
0
0 
0.
0
9
1 
 
Table 16: Effect of therapy on HbA1c 
Gro
ups 
Samples 
Statistics 
Paired Differences Paired t-Test 
findings 
G
ro
u
p
-A
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
9.
5
6 
A
F 
9.
4
3 
1% BT-AF 1
0 
0.
08
2 
0.
02
6 
4.
9
9 
<0.
00
1 
HS 
G
ro
u
p
-B
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
9.
4
6 
A
F 
9.
3
0 
2% BT-AF 1
0 
0.
15
1 
0.
04
8 
3.
3
6 
<0.
01 
S 
G
ro
u
p
-C
 
Mean Decr
ease  
in % 
Comp
arativ
e Pairs 
n ±S
D 
±S
E 
t P Rem
arks 
B
T 
9.
2
7 
A
F 
8.
7
7 
5% BT-AF 1
0 
0.
31
3 
0.
09
9 
5.
0
6 
<0.
00
1 
HS 
In symptom HbA1c, all the patients of Group-A and 
Group-C showed Highly significant response after the 
Follow-up period as the P value is <0.001. Group-B 
showed Significant response after the Follow-up 
period as the P value is <0.01.  
Table 17: HbA1c in Different Groups Comparisons 
Obs
erva
tion
s 
Descriptives ANOVA 
Co
mp
ari
ng 
Gro
ups 
n M
e
a
n 
±
S
D 
±
S
E 
Va
ria
nc
e 
Su
m 
of 
Sq
ua
re
s 
d
f 
M
ea
n 
S
q
u
ar
e 
F P Re
m
ar
ks 
Afte
r 
Foll
Gro
up-
A 
1
0 
9.
4
3 
0.
3
8
0.
1
2
Be
tw
ee
2.
44
5 
2 1.
2
2
1
0.
3
<
0.
0
S 
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ow-
up 
0 0 n 
Gr
ou
ps 
2 7 1 
Gro
up-
B 
1
0 
9.
3
0 
0.
2
6
3 
0.
0
8
3 
Gro
up-
C 
1
0 
8.
7
7 
0.
3
7
4 
0.
1
1
8 
Wi
thi
n 
Gr
ou
ps 
3.
18
2 
2
7 
0.
1
1
8 
Tot
al 
3
0 
9.
1
7 
0.
4
4
1 
0.
0
8
0 
DISCUSSION 
The Somavalka has been selected for the study 
because of direct indication of Somavalka Kashaya 
Niruhabasti by Charaka Samhita. The study is framed 
to evaluate the comparative effect in 3 Groups and 30 
patients were equally divided into three (i.e. 10 
patients in each groups) groups. Here the Somavalka 
Kashaya is used in all three groups; with Aavapa 
Dravyas (Amalaki, Haridra) and with Utklesh Dravyas 
(Yastimadhu, Kapitha), Doshahara Dravyas 
(Karavellka, Nimba), Dosha Shaman (Saptachakra, 
Jambu) under Trio-vasti pattern for 8- days (Yoga 
Basti Schedule). The treatment given to 30 patients 
includes Sthanika Abhyanga with Tilataila, 
Nadiswedana locally and Basti for 8- days. In this 
particular context the patients of Madhumeha 
presented with the symptoms like Prabhoota 
Mootrata, Aavila Mootrata, Pipasadikya, Kara-
Padadaha etc. and the aim was to control it, as 
Madhumeha is Kaphapradhana Vatavyadhi along with 
Kleda and Meda. Somavalka is having Tikta, Kashaya 
property and Ushnavirya, Kapha-Vatahara and 
Pramehahara property. 
Similarly Aavapa Dravyas bears Tikta, Kashaya Rasa, 
Ushnavirya and are also having Tridoshahara 
(Amalaki), Kapha- Vatahara, and Pramehahara 
property. 
Similarly Yastimadu is Tridoshahara, Kapita is Usna 
Veerya and having Kapha-Vatahara property. 
Karavelleka is Tikta, Katu, Usna Veerya, Kapha-Pitta 
Hara and Pramehahara property. Nimba is Tikta, 
Kashaya, Usnavirya, Kapha-Pitta Hara and 
Madhumehahara property. Saptachakra is Tikta, 
Kashaya, Usnavirya, Kapha-Pitta Hara and 
Madhumehahara property. Jambu is 
Kashayapradhana and Madhumehahara property. 
In Madhumeha, Vata gets alleviated by Basti by 
removing the Aavarana done by Kapha. So along with 
Vata, morbid Kapha is also expelled out. 
CONCLUSION 
Somavalka Kashya Yogabasti has shown good result in 
Madhumeha. Among Somavalka with Avapa Dravyas 
and Somavalka used in trio-Basti along with 
Utkleshana, Doshahara, Dosha Shaman,  the former 
has shown better result than the above treatment 
modality and later has shown very significant results 
than other two treatment modalities. Hence 
Somavalka Kashaya given in Trio-Basti pattern is an 
effective treatment in the management of 
Madhumeha. In mild and moderate type of 
Madhumeha patients, Somavalka Kashaya given in 
Trio-Basti helps in controlling it. 
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